Bristol-Myers Squibb股票因前景疲软而受到关注

Reported about 7 hours ago

Bristol-Myers Squibb（BMY）股票因公司前景疲软而备受关注，尽管其盈利超出预期。该制药公司强调其新一类抗精神病药物可能成为2025年的增长动力。

You may also interested in these wikis

Trump Treasury Secretary Bessent Eases Fed Pressure

KKR Increases Fuji Soft Bid Amid Bain Capital Competition

Tariffs: Trump and Xi Jinping's Unique Opportunity for a Trade Deal

Record Trading Volumes for US Ether ETFs Amid Trump Tariffs

Concerns Over Oil Supply Risks in Russia

China Targets US Energy Imports with New Tariffs

Is Disney Stock a Good Buy Under $120?

Investors Brace for Impact of Evolving US Tariff Threats

High Stakes for US Automakers Amid Trump Tariff Threats

BOJ's New Focus on Labor Shortages Signals Possible Rate Increases

Back to all Wikis